Trials / Completed
CompletedNCT03673995
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
Use of Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 186 (actual)
- Sponsor
- Pharmarte srl · Industry
- Sex
- Female
- Age
- 16 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Myo-inositol+L-tyrosine | PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal, hirsutism and ovulation assesment. |
Timeline
- Start date
- 2017-05-02
- Primary completion
- 2018-08-22
- Completion
- 2018-10-30
- First posted
- 2018-09-17
- Last updated
- 2020-06-16
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03673995. Inclusion in this directory is not an endorsement.